NCT04970927

Brief Summary

Cerebral Palsy (CP), is the most common cause of physical disability that begins in childhood and lasts throughout life, affecting 1 in 500 newborns, with an estimated prevalence of 17 million worldwide. Social isolation, economic conditions, interruption of treatments, etc. may cause physical, mental, behavioral and psychosocial changes in children with cerebral palsy. Discontinuing regular physiotherapy can worsen functional skills and cause complications in children with cerebral palsy. Our aim in this study is to investigate the sustainability of the treatments of children with cerebral palsy during the pandemic period, their physical and psychosocial effects, and the relationship between their parents' fear of covid-19.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 12, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 21, 2021

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2021

Completed
Last Updated

October 21, 2022

Status Verified

October 1, 2022

Enrollment Period

4 months

First QC Date

July 12, 2021

Last Update Submit

October 20, 2022

Conditions

Keywords

Cerebral PalsyCovid19Pandemics

Outcome Measures

Primary Outcomes (1)

  • Evaluation Survey

    A questionnaire form consisting of 19 questions and 3 parts prepared by the authors in the light of the information obtained during the clinical observation process of children with cerebral palsy will be used.

    First day

Secondary Outcomes (1)

  • Covid-19 Fear Scale

    First day

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

-Parents of children under the age of 18 with cerebral palsy who applied to our hospital between 01.01.2014-31.01.2021

You may qualify if:

  • Parents of children under the age of 18 with cerebral palsy who applied to our hospital between 01.01.2014-31.01.2021

You may not qualify if:

  • Parents of Cerebral Palsy Patients over 18 years of age
  • Parents who cannot be reached by phone
  • Parents who do not agree to fill out the questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sevda Adar

Merkez, Afyonkarahisar, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cerebral PalsyCOVID-19

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • SEVDA ADAR

    Afyonkarahisar Health Sciences University

    PRINCIPAL INVESTIGATOR
  • PETEK ŞARLAK KONYA

    Afyonkarahisar Health Sciences University

    STUDY CHAIR
  • ALİ İZZET AKÇİN

    Afyonkarahisar Health Sciences University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
assistant professor, medical doctor

Study Record Dates

First Submitted

July 12, 2021

First Posted

July 21, 2021

Study Start

April 15, 2021

Primary Completion

July 30, 2021

Study Completion

August 10, 2021

Last Updated

October 21, 2022

Record last verified: 2022-10

Locations